Signal active
Organization
Contact Information
Overview
Miromatrix Medical is a biotechnology company engaged in the development of fully biological human organs and organ-derived biological products to solve the chronic shortage of transplantable organs, utilizing its patented perfusion decellularization or recellularization technology, as well as organ-derived biological products for applications such as soft tissue reinforcement and advanced wound care.
It was founded in 2009 and is based in Eden Prairie, Minnesota.
About
Biotechnology, Health Care, Medical, Medical Device
2009
1001-5000
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Miromatrix Medical headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Medical Device sector. The company focuses on Biotechnology and has secured $10.3B in funding across 144 round(s). With a team of 1001-5000 employees, Miromatrix Medical is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Miromatrix Medical, raised $5.3M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
9
1
0
$71.5M
Details
3
Miromatrix Medical has raised a total of $71.5M in funding over 3 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2018 | Early Stage Venture | 15.7M | ||
2021 | Late Stage Venture | |||
2015 | Early Stage Venture | 23.3M |
Investors
Miromatrix Medical is funded by 5 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Miromatrix Medical | - | FUNDING ROUND - Miromatrix Medical | undefined |
CareDx | - | FUNDING ROUND - CareDx | undefined |
Miromatrix Medical | - | FUNDING ROUND - Miromatrix Medical | 1.0M |
National Science Foundation | - | FUNDING ROUND - National Science Foundation | 1.0M |
Recent Activity
There is no recent news or activity for this profile.